Thursday, August 28, 2008

Buy! Sell! Analysts Duke It Out Over Amylin

Amylin's share price fell 25% yesterday, on reports the company's diabetes drug Byetta has been linked to pancreatitis. Does that make the stock a bargain?
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)